CDMRP Breast Cancer Research Program Transformative Breast Cancer Consortium Award

The Transformative Breast Cancer Consortium Award is designed to support collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer.

The consortium should have 4-5 teams working on discrete projects under a central hypothesis. Maximum 2 projects may be at the same institutions. See additional information in attached document. 

It is expected that 1 award will be granted.

Funding: $25,000,000
Duration: 4 years

Research Authority due date: 27.7.22

Pre proposal (required) due date: 3.8.22
Full proposal due date: 2.11.22